|
1
|
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
|
JAMA
|
2011
|
16.68
|
|
2
|
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
|
Ann Surg
|
2010
|
7.97
|
|
3
|
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.
|
J Clin Oncol
|
2005
|
7.77
|
|
4
|
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
|
J Clin Oncol
|
2007
|
4.05
|
|
5
|
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.
|
J Clin Oncol
|
2005
|
3.83
|
|
6
|
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.
|
Cancer Res
|
2004
|
3.63
|
|
7
|
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.
|
Clin Cancer Res
|
2007
|
3.62
|
|
8
|
Mammography before diagnosis among women age 80 years and older with breast cancer.
|
J Clin Oncol
|
2008
|
3.49
|
|
9
|
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
|
JAMA
|
2013
|
3.38
|
|
10
|
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
|
Ann Surg Oncol
|
2006
|
2.84
|
|
11
|
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
|
Ann Surg Oncol
|
2007
|
2.72
|
|
12
|
Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.
|
Ann Surg Oncol
|
2006
|
2.69
|
|
13
|
Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites.
|
BMJ
|
2002
|
2.53
|
|
14
|
Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.
|
J Clin Oncol
|
2008
|
2.51
|
|
15
|
Long-term complications associated with breast-conservation surgery and radiotherapy.
|
Ann Surg Oncol
|
2002
|
2.51
|
|
16
|
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial.
|
Lancet Oncol
|
2013
|
2.47
|
|
17
|
Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.
|
Ann Surg Oncol
|
2006
|
2.43
|
|
18
|
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
|
J Clin Oncol
|
2012
|
2.40
|
|
19
|
A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.
|
Ann Surg Oncol
|
2008
|
2.39
|
|
20
|
Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.
|
Proc Natl Acad Sci U S A
|
2007
|
2.38
|
|
21
|
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
|
Cancer
|
2003
|
2.29
|
|
22
|
Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
|
JAMA
|
2011
|
2.28
|
|
23
|
Imaging features of primary breast sarcoma.
|
AJR Am J Roentgenol
|
2012
|
2.26
|
|
24
|
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
|
Ann Surg Oncol
|
2006
|
2.23
|
|
25
|
Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.
|
Clin Cancer Res
|
2009
|
2.22
|
|
26
|
Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
|
Cancer
|
2002
|
2.21
|
|
27
|
Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.
|
J Clin Oncol
|
2003
|
2.19
|
|
28
|
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.
|
Ann Surg Oncol
|
2008
|
2.17
|
|
29
|
Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients.
|
Ann Surg
|
2011
|
2.16
|
|
30
|
Extraosseous osteosarcoma: response to treatment and long-term outcome.
|
J Clin Oncol
|
2002
|
2.13
|
|
31
|
Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
|
Ann Surg Oncol
|
2010
|
2.12
|
|
32
|
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
|
J Clin Oncol
|
2004
|
2.00
|
|
33
|
Angiosarcoma of the breast.
|
Cancer
|
2005
|
1.98
|
|
34
|
Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.
|
Ann Surg Oncol
|
2011
|
1.93
|
|
35
|
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
|
Ann Surg Oncol
|
2007
|
1.92
|
|
36
|
Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy.
|
Plast Reconstr Surg
|
2007
|
1.86
|
|
37
|
Thermoacoustic and photoacoustic tomography of thick biological tissues toward breast imaging.
|
Technol Cancer Res Treat
|
2005
|
1.83
|
|
38
|
Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge.
|
J Am Coll Surg
|
2003
|
1.81
|
|
39
|
A management algorithm and practical oncoplastic surgical techniques for repairing partial mastectomy defects.
|
Plast Reconstr Surg
|
2008
|
1.81
|
|
40
|
Determining the optimal approach to breast reconstruction after partial mastectomy.
|
Plast Reconstr Surg
|
2006
|
1.80
|
|
41
|
Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma.
|
Am J Surg Pathol
|
2009
|
1.79
|
|
42
|
Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
|
Cancer
|
2010
|
1.79
|
|
43
|
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.
|
Cancer
|
2009
|
1.76
|
|
44
|
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
|
Ann Surg Oncol
|
2006
|
1.75
|
|
45
|
Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer.
|
Ann Surg Oncol
|
2003
|
1.74
|
|
46
|
Mammary angiosarcomas: imaging findings in 24 patients.
|
Radiology
|
2007
|
1.73
|
|
47
|
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
|
Ann Surg
|
2005
|
1.72
|
|
48
|
Timing of surgical intervention for the intact primary in stage IV breast cancer patients.
|
Ann Surg Oncol
|
2008
|
1.71
|
|
49
|
Treatment and outcome of patients with intracystic papillary carcinoma of the breast.
|
Am J Surg
|
2002
|
1.70
|
|
50
|
Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.
|
J Clin Oncol
|
2010
|
1.70
|
|
51
|
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
|
Ann Surg
|
2006
|
1.70
|
|
52
|
Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
|
Breast Cancer Res
|
2007
|
1.68
|
|
53
|
Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.67
|
|
54
|
Delayed-immediate breast reconstruction.
|
Plast Reconstr Surg
|
2004
|
1.66
|
|
55
|
Predicting the extent of nodal disease in early-stage breast cancer.
|
Ann Surg Oncol
|
2014
|
1.63
|
|
56
|
Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.
|
J Clin Oncol
|
2004
|
1.61
|
|
57
|
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
|
J Am Coll Surg
|
2005
|
1.61
|
|
58
|
Positive sentinel nodes without axillary dissection: implications for the radiation oncologist.
|
J Clin Oncol
|
2011
|
1.60
|
|
59
|
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
|
J Clin Oncol
|
2012
|
1.59
|
|
60
|
Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.
|
Ann Surg Oncol
|
2007
|
1.58
|
|
61
|
Primary angiosarcomas of the breast.
|
Cancer
|
2007
|
1.54
|
|
62
|
Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival.
|
Cancer
|
2007
|
1.54
|
|
63
|
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.
|
Ann Surg Oncol
|
2004
|
1.52
|
|
64
|
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.51
|
|
65
|
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.51
|
|
66
|
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
|
Cancer
|
2005
|
1.50
|
|
67
|
A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up.
|
Plast Reconstr Surg
|
2011
|
1.48
|
|
68
|
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
|
Breast Cancer Res
|
2014
|
1.46
|
|
69
|
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
|
Cancer
|
2002
|
1.45
|
|
70
|
Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer.
|
Ann Surg Oncol
|
2003
|
1.45
|
|
71
|
Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients.
|
Ann Surg Oncol
|
2010
|
1.45
|
|
72
|
Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?
|
Am J Surg
|
2003
|
1.45
|
|
73
|
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.
|
Ann Surg Oncol
|
2011
|
1.44
|
|
74
|
Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes.
|
Ann Surg Oncol
|
2014
|
1.44
|
|
75
|
Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy.
|
Plast Reconstr Surg
|
2011
|
1.42
|
|
76
|
Development of Ad-mda7/IL-24-resistant lung cancer cell lines.
|
Cancer Biol Ther
|
2007
|
1.42
|
|
77
|
Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.
|
Cancer Res
|
2008
|
1.41
|
|
78
|
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.
|
Ann Surg
|
2005
|
1.39
|
|
79
|
Translation initiation in cancer: a novel target for therapy.
|
Mol Cancer Ther
|
2002
|
1.39
|
|
80
|
Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
|
Cancer
|
2007
|
1.38
|
|
81
|
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
|
Cancer Prev Res (Phila)
|
2010
|
1.35
|
|
82
|
Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model.
|
Cancer Res
|
2008
|
1.34
|
|
83
|
A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility.
|
Ann Surg Oncol
|
2002
|
1.33
|
|
84
|
Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.
|
Am J Surg
|
2003
|
1.33
|
|
85
|
Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.
|
J Am Coll Surg
|
2009
|
1.33
|
|
86
|
Angiosarcoma: clinical and molecular insights.
|
Ann Surg
|
2010
|
1.33
|
|
87
|
Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
|
Cancer
|
2007
|
1.32
|
|
88
|
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.
|
J Clin Oncol
|
2007
|
1.32
|
|
89
|
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
|
Ann Surg
|
2016
|
1.30
|
|
90
|
Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
|
J Natl Cancer Inst
|
2012
|
1.30
|
|
91
|
American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.
|
Ann Surg Oncol
|
2012
|
1.29
|
|
92
|
Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study.
|
AJR Am J Roentgenol
|
2008
|
1.29
|
|
93
|
Adenoviral gene therapy.
|
Oncologist
|
2002
|
1.26
|
|
94
|
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
|
Int Immunopharmacol
|
2004
|
1.26
|
|
95
|
Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer.
|
Oncogene
|
2004
|
1.26
|
|
96
|
Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR).
|
Cancer Res
|
2002
|
1.26
|
|
97
|
Imaging differences in metaplastic and invasive ductal carcinomas of the breast.
|
AJR Am J Roentgenol
|
2007
|
1.26
|
|
98
|
Multidisciplinary management of breast cancer concurrent with pregnancy.
|
J Am Coll Surg
|
2002
|
1.25
|
|
99
|
Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
|
J Clin Oncol
|
2004
|
1.25
|
|
100
|
Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR.
|
Mol Ther
|
2005
|
1.23
|
|
101
|
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.
|
J Clin Oncol
|
2002
|
1.20
|
|
102
|
Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.
|
Oncogene
|
2002
|
1.20
|
|
103
|
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.20
|
|
104
|
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry.
|
Breast Cancer Res Treat
|
2005
|
1.20
|
|
105
|
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer.
|
Cancer
|
2004
|
1.18
|
|
106
|
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
|
Cancer
|
2004
|
1.18
|
|
107
|
Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer.
|
Cancer
|
2010
|
1.18
|
|
108
|
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.17
|
|
109
|
Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
|
Am J Surg
|
2007
|
1.16
|
|
110
|
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.
|
Cancer
|
2009
|
1.16
|
|
111
|
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
|
Breast Cancer Res
|
2012
|
1.16
|
|
112
|
Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
|
Cancer
|
2004
|
1.16
|
|
113
|
Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).
|
Ann Surg
|
2015
|
1.15
|
|
114
|
Locoregional treatment outcomes after multimodality management of inflammatory breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.15
|
|
115
|
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.
|
Hum Pathol
|
2011
|
1.14
|
|
116
|
Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
|
Cancer
|
2005
|
1.14
|
|
117
|
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.
|
J Gastrointest Surg
|
2004
|
1.14
|
|
118
|
Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery.
|
Am J Surg
|
2009
|
1.13
|
|
119
|
Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
|
Ann Surg
|
2014
|
1.12
|
|
120
|
The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.
|
Ann Surg Oncol
|
2012
|
1.12
|
|
121
|
Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.
|
Cancer
|
2010
|
1.11
|
|
122
|
Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
|
Ann Surg
|
2012
|
1.10
|
|
123
|
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.10
|
|
124
|
How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?
|
Cancer
|
2008
|
1.10
|
|
125
|
Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
|
BMC Cancer
|
2006
|
1.10
|
|
126
|
Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.
|
J Am Coll Surg
|
2012
|
1.09
|
|
127
|
Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons.
|
Ann Surg Oncol
|
2012
|
1.09
|
|
128
|
Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death.
|
Ann Surg Oncol
|
2011
|
1.08
|
|
129
|
Chest wall recurrence after mastectomy does not always portend a dismal outcome.
|
Ann Surg Oncol
|
2003
|
1.08
|
|
130
|
Improving local control with breast-conserving therapy: a 27-year single-institution experience.
|
Cancer
|
2005
|
1.08
|
|
131
|
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
|
Ann Surg
|
2016
|
1.07
|
|
132
|
Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
|
Cancer
|
2006
|
1.07
|
|
133
|
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
|
PLoS Genet
|
2012
|
1.07
|
|
134
|
Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
|
Am J Surg
|
2006
|
1.07
|
|
135
|
Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.
|
Cancer Res
|
2010
|
1.06
|
|
136
|
MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells.
|
Mol Ther
|
2003
|
1.06
|
|
137
|
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
|
Cancer
|
2002
|
1.06
|
|
138
|
Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
|
Cancer
|
2006
|
1.06
|
|
139
|
A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
|
J Am Coll Surg
|
2004
|
1.05
|
|
140
|
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
|
Ann Surg
|
2011
|
1.05
|
|
141
|
Selective use of sentinel lymph node surgery during prophylactic mastectomy.
|
Cancer
|
2006
|
1.05
|
|
142
|
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.04
|
|
143
|
Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation.
|
Cancer Res
|
2009
|
1.04
|
|
144
|
Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer.
|
Breast Cancer Res
|
2004
|
1.04
|
|
145
|
Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.
|
Cancer
|
2003
|
1.04
|
|
146
|
Outcome after curative resection for locally recurrent rectal cancer.
|
Dis Colon Rectum
|
2006
|
1.04
|
|
147
|
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma.
|
J Clin Oncol
|
2003
|
1.04
|
|
148
|
Breast conservation after neoadjuvant chemotherapy.
|
Cancer
|
2005
|
1.04
|
|
149
|
Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.
|
Cancer Immunol Immunother
|
2006
|
1.03
|
|
150
|
Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.
|
Ann Surg
|
2006
|
1.03
|
|
151
|
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
|
Cancer
|
2004
|
1.03
|
|
152
|
Staging of breast cancer in the neoadjuvant setting.
|
Cancer Res
|
2008
|
1.03
|
|
153
|
Triple-negative breast cancer is not a contraindication for breast conservation.
|
Ann Surg Oncol
|
2011
|
1.03
|
|
154
|
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.
|
Ann Surg Oncol
|
2013
|
1.02
|
|
155
|
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas.
|
Ann Surg Oncol
|
2006
|
1.02
|
|
156
|
Tumor volume as a prognostic factor for sarcomatosis.
|
Cancer
|
2002
|
1.02
|
|
157
|
Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.
|
J Clin Oncol
|
2011
|
1.02
|
|
158
|
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
|
J Clin Oncol
|
2011
|
1.02
|
|
159
|
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.
|
Ann Surg Oncol
|
2002
|
1.02
|
|
160
|
Biology, treatment, and outcome in very young and older women with DCIS.
|
Ann Surg Oncol
|
2012
|
1.02
|
|
161
|
Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells.
|
Surgery
|
2004
|
1.01
|
|
162
|
Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.
|
Clin Cancer Res
|
2010
|
1.01
|
|
163
|
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years.
|
Carcinogenesis
|
2006
|
1.00
|
|
164
|
Does blue dye contribute to success of sentinel node mapping for breast cancer?
|
Ann Surg Oncol
|
2010
|
0.99
|
|
165
|
Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.
|
Ann Surg Oncol
|
2009
|
0.99
|
|
166
|
Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer.
|
Ann Surg Oncol
|
2012
|
0.99
|
|
167
|
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.
|
PLoS Med
|
2009
|
0.99
|
|
168
|
Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug.
|
Mol Cell Proteomics
|
2010
|
0.98
|
|
169
|
High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study.
|
Biomed Opt Express
|
2010
|
0.98
|
|
170
|
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas.
|
Ann Surg
|
2007
|
0.98
|
|
171
|
Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas.
|
Cancer
|
2008
|
0.98
|
|
172
|
Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
|
Cancer Res
|
2007
|
0.97
|
|
173
|
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.97
|
|
174
|
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
|
Ann Surg
|
2013
|
0.97
|
|
175
|
Nipple aspirate fluid cytology in breast carcinoma.
|
Cancer
|
2003
|
0.97
|
|
176
|
A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.
|
Cancer
|
2010
|
0.97
|
|
177
|
HER2/neu in the management of invasive breast cancer.
|
J Am Coll Surg
|
2002
|
0.96
|
|
178
|
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
|
Cancer
|
2005
|
0.96
|
|
179
|
Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer.
|
Am J Surg
|
2005
|
0.96
|
|
180
|
Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma.
|
Clin Cancer Res
|
2012
|
0.95
|
|
181
|
Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas.
|
Cancer
|
2002
|
0.95
|
|
182
|
Paget's disease of the breast: there is a role for breast-conserving therapy.
|
Ann Surg Oncol
|
2005
|
0.95
|
|
183
|
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
|
Ann Surg Oncol
|
2006
|
0.95
|
|
184
|
Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer.
|
Ann Surg Oncol
|
2011
|
0.95
|
|
185
|
Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
|
Surgery
|
2012
|
0.94
|
|
186
|
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients.
|
Ann Surg Oncol
|
2013
|
0.94
|
|
187
|
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
|
Am J Surg
|
2008
|
0.94
|
|
188
|
Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
|
Cancer
|
2010
|
0.94
|
|
189
|
Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.
|
Cancer
|
2012
|
0.93
|
|
190
|
Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.
|
J Am Coll Surg
|
2006
|
0.93
|
|
191
|
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer.
|
Clin Cancer Res
|
2003
|
0.93
|
|
192
|
Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy.
|
Plast Reconstr Surg
|
2013
|
0.93
|
|
193
|
Immediate breast reconstruction can impact postmastectomy irradiation.
|
Am J Clin Oncol
|
2005
|
0.93
|
|
194
|
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.
|
Breast Cancer Res
|
2012
|
0.93
|
|
195
|
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
|
Ann Surg Oncol
|
2010
|
0.92
|
|
196
|
Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.
|
Cancer
|
2010
|
0.92
|
|
197
|
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.92
|
|
198
|
Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.
|
Oncogene
|
2002
|
0.92
|
|
199
|
Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
|
J Clin Oncol
|
2006
|
0.92
|
|
200
|
The neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer.
|
Cancer Res
|
2010
|
0.92
|
|
201
|
Follicular dendritic cell sarcoma and associated myasthenia gravis: true, true, related?
|
J Clin Oncol
|
2011
|
0.92
|
|
202
|
Targeting low molecular weight cyclin E (LMW-E) in breast cancer.
|
Breast Cancer Res Treat
|
2011
|
0.91
|
|
203
|
Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.91
|
|
204
|
Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.
|
Clin Cancer Res
|
2008
|
0.91
|
|
205
|
Significance and management of micrometastases in patients with breast cancer.
|
Expert Rev Anticancer Ther
|
2007
|
0.91
|
|
206
|
Pleomorphic ductal carcinoma of the breast: predictors of decreased overall survival.
|
Am J Surg Pathol
|
2010
|
0.90
|
|
207
|
Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo.
|
Mol Cancer Ther
|
2005
|
0.90
|
|
208
|
Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer.
|
Surgery
|
2005
|
0.90
|
|
209
|
Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?
|
Ann Surg Oncol
|
2014
|
0.90
|
|
210
|
The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation.
|
Clin Cancer Res
|
2007
|
0.90
|
|
211
|
Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment.
|
Cancer
|
2010
|
0.90
|
|
212
|
Accelerated partial breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast cancer in the setting of breast augmentation.
|
Brachytherapy
|
2010
|
0.90
|
|
213
|
Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction.
|
Am J Surg
|
2004
|
0.89
|
|
214
|
Radiofrequency ablation of early-stage invasive breast tumors: an overview.
|
Cancer J
|
2002
|
0.89
|
|
215
|
Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center.
|
Am J Surg
|
2006
|
0.89
|
|
216
|
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.89
|
|
217
|
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer.
|
Breast Cancer Res
|
2013
|
0.88
|
|
218
|
Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.
|
Stat Med
|
2014
|
0.88
|
|
219
|
Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.
|
Cancer
|
2010
|
0.88
|
|
220
|
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
|
J Clin Oncol
|
2004
|
0.88
|
|
221
|
Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells.
|
Cell Cycle
|
2010
|
0.87
|
|
222
|
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
|
Cancer
|
2006
|
0.87
|
|
223
|
Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways.
|
Ann Surg
|
2006
|
0.87
|
|
224
|
Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy.
|
Cancer
|
2007
|
0.87
|
|
225
|
Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
|
Cancer
|
2004
|
0.87
|
|
226
|
Implications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction.
|
Plast Reconstr Surg
|
2002
|
0.87
|
|
227
|
Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
|
Ann Surg Oncol
|
2007
|
0.87
|
|
228
|
Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast.
|
Am J Surg
|
2007
|
0.86
|
|
229
|
Sentinel lymph node surgery in locally recurrent breast cancer.
|
Clin Breast Cancer
|
2006
|
0.86
|
|
230
|
Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?
|
Cancer
|
2006
|
0.86
|
|
231
|
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
|
Ann Surg Oncol
|
2013
|
0.86
|
|
232
|
Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.
|
Ann Surg Oncol
|
2013
|
0.86
|
|
233
|
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.
|
Mol Cancer Ther
|
2008
|
0.86
|
|
234
|
Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas.
|
Clin Cancer Res
|
2009
|
0.86
|
|
235
|
Adverse events associated with the intraoperative injection of isosulfan blue.
|
J Clin Anesth
|
2004
|
0.85
|
|
236
|
Breast cancer and lymphedema: a current overview for the healthcare provider.
|
Womens Health (Lond Engl)
|
2010
|
0.85
|
|
237
|
Genetically targeted cancer therapy: tumor destruction by PKR activation.
|
Am J Pharmacogenomics
|
2004
|
0.85
|
|
238
|
Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.
|
Cancer Res
|
2013
|
0.85
|
|
239
|
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control.
|
Breast Cancer Res Treat
|
2011
|
0.85
|
|
240
|
Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.85
|
|
241
|
Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.85
|
|
242
|
Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States.
|
Cancer
|
2012
|
0.85
|
|
243
|
Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
|
Surgery
|
2005
|
0.85
|
|
244
|
Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.
|
Ann Surg Oncol
|
2014
|
0.84
|
|
245
|
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.84
|
|
246
|
A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping.
|
Cancer
|
2004
|
0.84
|
|
247
|
Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.
|
Ann Surg Oncol
|
2010
|
0.84
|
|
248
|
Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.
|
Cancer
|
2007
|
0.83
|
|
249
|
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
|
Cancer
|
2006
|
0.83
|
|
250
|
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression.
|
Mod Pathol
|
2008
|
0.83
|
|
251
|
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.83
|
|
252
|
Lymphatic interrupted: do we really understand the risks and consequences?
|
Ann Surg Oncol
|
2009
|
0.83
|
|
253
|
The mitochondrial apoptosis-inducing factor plays a role in E2F-1-induced apoptosis in human colon cancer cells.
|
Ann Surg Oncol
|
2003
|
0.83
|
|
254
|
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years.
|
Breast Cancer Res Treat
|
2007
|
0.83
|
|
255
|
Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma.
|
Cancer
|
2005
|
0.83
|
|
256
|
Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
|
Cancer
|
2004
|
0.83
|
|
257
|
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.
|
Ann Surg Oncol
|
2014
|
0.82
|
|
258
|
Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer.
|
J Am Coll Surg
|
2006
|
0.82
|
|
259
|
Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group.
|
Surgery
|
2006
|
0.82
|
|
260
|
Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study.
|
Cancer
|
2004
|
0.82
|
|
261
|
Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials.
|
Cancer
|
2011
|
0.82
|
|
262
|
Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer.
|
Arch Pathol Lab Med
|
2009
|
0.82
|
|
263
|
Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.
|
Cancer
|
2014
|
0.82
|
|
264
|
Prospective evaluation of a novel approach for the use of a quantitative galactose oxidase-Schiff reaction in ductal fluid samples from women with breast carcinoma.
|
Cancer
|
2004
|
0.82
|
|
265
|
Improved postoperative pain control using thoracic paravertebral block for breast operations.
|
Breast J
|
2009
|
0.81
|
|
266
|
Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery.
|
Cancer
|
2002
|
0.81
|
|
267
|
Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1.
|
J Gastrointest Surg
|
2009
|
0.81
|
|
268
|
Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy.
|
Ann Surg Oncol
|
2012
|
0.81
|
|
269
|
Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.
|
Am J Surg
|
2009
|
0.81
|
|
270
|
Breast-conservation therapy in early-stage breast cancer patients with a positive family history.
|
Ann Surg Oncol
|
2002
|
0.81
|
|
271
|
Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.80
|
|
272
|
Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.
|
Histopathology
|
2012
|
0.80
|
|
273
|
Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
|
Breast Cancer Res Treat
|
2003
|
0.80
|
|
274
|
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.
|
Breast Cancer Res Treat
|
2012
|
0.80
|
|
275
|
A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.
|
Stat Med
|
2012
|
0.79
|
|
276
|
Now and later? The sticky question of lymph node management in patients receiving preoperative chemotherapy.
|
Ann Surg Oncol
|
2005
|
0.79
|
|
277
|
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.
|
Cancer
|
2008
|
0.79
|
|
278
|
Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management.
|
Asian J Surg
|
2004
|
0.79
|
|
279
|
The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore.
|
Curr Opin Obstet Gynecol
|
2011
|
0.79
|
|
280
|
Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.79
|
|
281
|
Radiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer.
|
Surg Clin North Am
|
2003
|
0.79
|
|
282
|
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.
|
Cancer
|
2012
|
0.79
|
|
283
|
Unsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies.
|
Technol Cancer Res Treat
|
2006
|
0.79
|
|
284
|
Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.
|
Ann Surg Oncol
|
2011
|
0.79
|
|
285
|
Determinants of mastectomy in breast conservation therapy candidates.
|
Am J Surg
|
2005
|
0.79
|
|
286
|
Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
|
Clin Nucl Med
|
2005
|
0.78
|
|
287
|
Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer.
|
Ann Surg Oncol
|
2015
|
0.78
|
|
288
|
Impact of sentinel lymph node biopsy on the evolution of breast reconstruction.
|
Plast Reconstr Surg
|
2006
|
0.78
|
|
289
|
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
|
J Interferon Cytokine Res
|
2002
|
0.78
|
|
290
|
Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry.
|
Cancer
|
2009
|
0.78
|
|
291
|
Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.78
|
|
292
|
Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
|
Ann Surg
|
2016
|
0.77
|
|
293
|
Management of breast carcinoma identified intraoperatively during reduction mammaplasty.
|
Ann Plast Surg
|
2003
|
0.77
|
|
294
|
Sentinel lymph node dissection is technically feasible in older breast cancer patients.
|
Clin Breast Cancer
|
2010
|
0.77
|
|
295
|
Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer.
|
Surgery
|
2004
|
0.77
|
|
296
|
Surgical considerations in patients receiving neoadjuvant systemic therapy.
|
Future Oncol
|
2012
|
0.77
|
|
297
|
Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States.
|
Ann Surg Oncol
|
2011
|
0.77
|
|
298
|
Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
|
Am J Surg
|
2005
|
0.77
|
|
299
|
Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.
|
Breast J
|
2011
|
0.77
|
|
300
|
Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin.
|
Ann Surg
|
2010
|
0.77
|
|
301
|
Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.
|
Ann Surg
|
2004
|
0.77
|
|
302
|
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.
|
Ann Surg
|
2017
|
0.76
|
|
303
|
Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release.
|
J Thorac Cardiovasc Surg
|
2003
|
0.76
|
|
304
|
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.
|
Cancer
|
2011
|
0.76
|
|
305
|
Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
|
Ann Surg Oncol
|
2013
|
0.76
|
|
306
|
Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner.
|
Carcinogenesis
|
2013
|
0.76
|
|
307
|
Experimental approaches to treatment of soft tissue sarcoma.
|
Surg Oncol Clin N Am
|
2003
|
0.76
|
|
308
|
False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden.
|
Breast J
|
2009
|
0.76
|
|
309
|
Breast conservation therapy in the 21st century.
|
Breast J
|
2011
|
0.75
|
|
310
|
Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients.
|
J Gastrointest Surg
|
2015
|
0.75
|
|
311
|
Axillary Surgery After Chemotherapy: Challenges and Opportunities.
|
Oncology (Williston Park)
|
2015
|
0.75
|
|
312
|
Response to the letter to the editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: a practice-changing trial.
|
Ann Surg Oncol
|
2011
|
0.75
|
|
313
|
Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer.
|
Ann Surg Oncol
|
2009
|
0.75
|
|
314
|
Following the data: past, present, and future management of the axilla in breast cancer patients.
|
Oncology (Williston Park)
|
2014
|
0.75
|
|
315
|
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.
|
Oncology
|
2009
|
0.75
|
|
316
|
Comparative effectiveness of magnetic resonance imaging in breast cancer.
|
J Am Coll Surg
|
2012
|
0.75
|
|
317
|
Expanding the indications for sentinel lymph node surgery in breast cancer.
|
Future Oncol
|
2007
|
0.75
|
|
318
|
Response to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options.
|
Bull Am Coll Surg
|
2015
|
0.75
|
|
319
|
Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation.
|
Ann Surg Oncol
|
2014
|
0.75
|
|
320
|
Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer.
|
Cancer
|
2010
|
0.75
|
|
321
|
In brief.
|
Curr Probl Surg
|
2008
|
0.75
|
|
322
|
Needle localization for excisional biopsy of breast lesions: comparison of effect of use of full-field digital versus screen-film mammographic guidance on procedure time.
|
Radiology
|
2004
|
0.75
|
|
323
|
Recent advances in the hormonal treatment of breast cancer.
|
Curr Probl Surg
|
2008
|
0.75
|
|
324
|
SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy.
|
Bull Am Coll Surg
|
2014
|
0.75
|
|
325
|
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).
|
Ann Surg
|
2017
|
0.75
|
|
326
|
New manual for cancer surgery issued: Operative Standards for Cancer Surgery.
|
Bull Am Coll Surg
|
2015
|
0.75
|
|
327
|
Characteristics and Treatment of Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma Presenting with Aggressive Features.
|
Plast Reconstr Surg
|
2015
|
0.75
|
|
328
|
Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma.
|
Clin Breast Cancer
|
2010
|
0.75
|
|
329
|
Biomarkers in neoadjuvant trials.
|
Cancer Treat Res
|
2009
|
0.75
|
|
330
|
The role of surgery in the multidisciplinary management of patients with localized gastrointestinal stromal tumors.
|
Expert Rev Anticancer Ther
|
2012
|
0.75
|
|
331
|
Challenging a traditional paradigm: 12-year experience with autologous free flap breast reconstruction for inflammatory breast cancer.
|
Plast Reconstr Surg
|
2015
|
0.75
|
|
332
|
Spotlight on neoadjuvant therapy for breast cancer.
|
Ann Surg Oncol
|
2015
|
0.75
|
|
333
|
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
|
Ann Surg
|
2017
|
0.75
|
|
334
|
Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.
|
Breast Cancer Res Treat
|
2009
|
0.75
|
|
335
|
The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast.
|
Breast J
|
2006
|
0.75
|